A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity.

PubWeight™: 1.34‹?› | Rank: Top 10%

🔗 View Article (PMC 2169524)

Published in Mol Microbiol on July 19, 2007

Authors

Iris Fedtke1, Diana Mader, Thomas Kohler, Hermann Moll, Graeme Nicholson, Raja Biswas, Katja Henseler, Friedrich Götz, Ulrich Zähringer, Andreas Peschel

Author Affiliations

1: Cellular and Molecular Microbiology Division, University of Tübingen, Department of Medical Microbiology and Hygiene, 72076 Tübingen, Germany.

Articles citing this

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev (2010) 4.76

c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress. PLoS Pathog (2011) 2.55

Molecular control of bacterial death and lysis. Microbiol Mol Biol Rev (2008) 2.52

Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem (2010) 2.15

Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus. Proc Natl Acad Sci U S A (2010) 1.82

Pleiotropic roles of polyglycerolphosphate synthase of lipoteichoic acid in growth of Staphylococcus aureus cells. J Bacteriol (2008) 1.67

Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol (2008) 1.60

Bacterial lipids: metabolism and membrane homeostasis. Prog Lipid Res (2013) 1.42

Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes. FEMS Microbiol Lett (2011) 1.30

Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One (2010) 1.29

Cell surface of Lactococcus lactis is covered by a protective polysaccharide pellicle. J Biol Chem (2010) 1.29

Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes. PLoS One (2009) 1.18

Two-enzyme systems for glycolipid and polyglycerolphosphate lipoteichoic acid synthesis in Listeria monocytogenes. Mol Microbiol (2009) 1.13

Enzymatic activities and functional interdependencies of Bacillus subtilis lipoteichoic acid synthesis enzymes. Mol Microbiol (2010) 1.03

Penetration of the blood-brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid. J Mol Med (Berl) (2010) 0.99

Deletion of the glycosyltransferase bgsB of Enterococcus faecalis leads to a complete loss of glycolipids from the cell membrane and to impaired biofilm formation. BMC Microbiol (2011) 0.88

Staphylococcus aureus and Bacillus subtilis W23 make polyribitol wall teichoic acids using different enzymatic pathways. Chem Biol (2010) 0.86

Intra- and inter-species interactions within biofilms of important foodborne bacterial pathogens. Front Microbiol (2015) 0.86

Synergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureus. PLoS One (2012) 0.86

Differential localization of LTA synthesis proteins and their interaction with the cell division machinery in Staphylococcus aureus. Mol Microbiol (2014) 0.84

Lipoteichoic acid in Streptomyces hygroscopicus: structural model and immunomodulatory activities. PLoS One (2011) 0.84

Global transcriptome analysis of Lactococcus garvieae strains in response to temperature. PLoS One (2013) 0.83

Lipoteichoic acids, phosphate-containing polymers in the envelope of gram-positive bacteria. J Bacteriol (2014) 0.83

Rapid analysis of Listeria monocytogenes cell wall teichoic acid carbohydrates by ESI-MS/MS. PLoS One (2011) 0.83

Generation of ramoplanin-resistant Staphylococcus aureus. FEMS Microbiol Lett (2010) 0.82

Serum Lipoproteins Are Critical for Pulmonary Innate Defense against Staphylococcus aureus Quorum Sensing. J Immunol (2015) 0.81

Streptococcus uberis strains isolated from the bovine mammary gland evade immune recognition by mammary epithelial cells, but not of macrophages. Vet Res (2016) 0.78

Cholate-stimulated biofilm formation by Lactococcus lactis cells. Appl Environ Microbiol (2011) 0.78

Chemical Genetic Analysis and Functional Characterization of Staphylococcal Wall Teichoic Acid 2-Epimerases Reveals Unconventional Antibiotic Drug Targets. PLoS Pathog (2016) 0.78

Altered lipid composition in Streptococcus pneumoniae cpoA mutants. BMC Microbiol (2014) 0.77

Staphylococcus aureus lipoteichoic acid inhibits platelet activation and thrombus formation via the Paf receptor. J Infect Dis (2013) 0.77

Oligopolyphenylenevinylene-conjugated oligoelectrolyte membrane insertion molecules selectively disrupt cell envelopes of Gram-positive bacteria. Appl Environ Microbiol (2015) 0.75

Equilibrium binding behavior of magnesium to wall teichoic acid. Biochim Biophys Acta (2015) 0.75

Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment. Sci Rep (2016) 0.75

Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus. Front Microbiol (2016) 0.75

Articles cited by this

A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 173.74

Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet (2006) 15.99

Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev (2000) 9.83

Genetic systems in staphylococci. Methods Enzymol (1991) 9.00

Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev (1999) 7.76

New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ Microbiol (2004) 7.40

The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun (1999) 7.22

Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol (1996) 7.16

Surface protein adhesins of Staphylococcus aureus. Trends Microbiol (1998) 6.86

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem (1999) 6.44

Staphylococcus and biofilms. Mol Microbiol (2002) 6.39

Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med (2004) 5.21

A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev (2003) 5.18

Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol Lett (1997) 5.02

The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol (2006) 4.29

Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect Immun (1996) 3.95

Lipoproteins of gram-positive bacteria. J Bacteriol (1995) 3.83

Transposon Tn554: complete nucleotide sequence and isolation of transposition-defective and antibiotic-sensitive mutants. EMBO J (1985) 3.68

Two restriction and modification systems in Staphylococcus aureus NCTC8325. J Gen Microbiol (1976) 3.64

Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. FEMS Microbiol Lett (1990) 3.45

Autolysins of Bacillus subtilis: multiple enzymes with multiple functions. Microbiology (2000) 3.18

Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med (2001) 3.09

Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect Immun (2001) 2.96

A series of shuttle vectors for Bacillus subtilis and Escherichia coli. Gene (1992) 2.77

Physiology of lipoteichoic acids in bacteria. Adv Microb Physiol (1988) 2.77

The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob Agents Chemother (2000) 2.71

Regulation of sigmaB-dependent transcription of sigB and asp23 in two different Staphylococcus aureus strains. Mol Gen Genet (1999) 2.62

Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway. J Bacteriol (2006) 2.49

Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus bacteriolytic enzymes by polyacrylamide gel electrophoresis. J Bacteriol (1990) 2.47

Surface proteins and the pathogenic potential of Listeria monocytogenes. Trends Microbiol (2002) 2.24

Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest (2005) 2.07

Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc Natl Acad Sci U S A (2007) 2.06

Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis (2002) 2.05

The function of teichoic acids in cation control in bacterial membranes. Biochem J (1973) 1.98

Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol (1987) 1.82

Versatility of pneumococcal surface proteins. Microbiology (2006) 1.80

Surface adhesins of Staphylococcus aureus. Adv Microb Physiol (2006) 1.77

Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol (2006) 1.72

Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities. Antimicrob Agents Chemother (1998) 1.50

Genes required for glycolipid synthesis and lipoteichoic acid anchoring in Staphylococcus aureus. J Bacteriol (2007) 1.48

Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides (2001) 1.47

Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect Immun (2006) 1.47

Staphylococcus aureus interactions with the endothelium: the role of bacterial "secretable expanded repertoire adhesive molecules" (SERAM) in disturbing host defense systems. Thromb Haemost (2005) 1.44

Teichoic acid content in different lineages of Staphylococcus aureus NCTC8325. Arch Microbiol (1998) 1.37

Comparison of contact angles and adhesion to hexadecane of urogenital, dairy, and poultry lactobacilli: effect of serial culture passages. Appl Environ Microbiol (1992) 1.33

Comparison of ribitol and glycerol teichoic acid genes in Bacillus subtilis W23 and 168: identical function, similar divergent organization, but different regulation. Microbiology (2002) 1.33

A UDP glucosyltransferase from Bacillus subtilis successively transfers up to four glucose residues to 1,2-diacylglycerol: expression of ypfP in Escherichia coli and structural analysis of its reaction products. Mol Microbiol (1998) 1.33

Biosynthesis of the glycolipid anchor in lipoteichoic acid of Staphylococcus aureus RN4220: role of YpfP, the diglucosyldiacylglycerol synthase. J Bacteriol (2001) 1.27

Comparative studies of lipoteichoic acids from several Bacillus strains. J Bacteriol (1986) 1.10

Novel processive and nonprocessive glycosyltransferases from Staphylococcus aureus and Arabidopsis thaliana synthesize glycoglycerolipids, glycophospholipids, glycosphingolipids and glycosylsterols. Eur J Biochem (2000) 1.09

Chemical composition and structure of cell wall teichoic acids of staphylococci. Arch Microbiol (1983) 1.08

D-alanyl-lipoteichoic acid in Lactobacillus casei: secretion of vesicles in response to benzylpenicillin. J Gen Microbiol (1992) 0.98

Beta-glucoside kinase (BglK) from Klebsiella pneumoniae. Purification, properties, and preparative synthesis of 6-phospho-beta-D-glucosides. J Biol Chem (2002) 0.88

A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues. Bioorg Med Chem (2006) 0.78

Articles by these authors

Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med (2007) 7.75

Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science (2003) 7.49

Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med (2004) 5.21

CD36 is a sensor of diacylglycerides. Nature (2005) 5.20

Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol (2003) 3.71

Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol (2008) 3.57

Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem (2003) 3.13

Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med (2004) 2.96

Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol (2005) 2.76

Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe (2010) 2.64

Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol (2005) 2.61

Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med (2006) 2.53

Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe (2010) 2.49

Innate immunity in Arabidopsis thaliana: lipopolysaccharides activate nitric oxide synthase (NOS) and induce defense genes. Proc Natl Acad Sci U S A (2004) 2.40

Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol (2006) 2.40

Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect Immun (2010) 2.33

Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2007) 2.14

Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun (2006) 2.13

Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest (2005) 2.07

Activity of the major staphylococcal autolysin Atl. FEMS Microbiol Lett (2006) 2.06

Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis (2002) 2.05

D-alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J Bacteriol (2005) 2.04

Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J Biol Chem (2005) 2.00

Large-conductance calcium-activated potassium channel activity is absent in human and mouse neutrophils and is not required for innate immunity. Am J Physiol Cell Physiol (2007) 1.99

DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect Immun (2005) 1.97

De Novo Arteriovenous Malformation Growth Secondary to Implantation of Genetically Modified Allogeneic Mesenchymal Stem Cells in the Brain. Neurosurgery (2016) 1.96

The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog (2009) 1.94

Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog (2007) 1.92

Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis (2005) 1.90

Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog (2009) 1.89

Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol Microbiol (2010) 1.82

MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol Lett (2004) 1.81

In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry. Microbiology (2007) 1.80

Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun (2005) 1.80

Comparative proteome analysis of Staphylococcus aureus biofilm and planktonic cells and correlation with transcriptome profiling. Proteomics (2006) 1.79

The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int J Med Microbiol (2009) 1.79

Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains. Antimicrob Agents Chemother (2009) 1.76

Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun (2005) 1.76

Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res (2011) 1.76

Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins. Cell Microbiol (2004) 1.74

Defensins from insects and plants interact with fungal glucosylceramides. J Biol Chem (2003) 1.70

A functional dlt operon, encoding proteins required for incorporation of d-alanine in teichoic acids in gram-positive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae. J Bacteriol (2006) 1.69

Bacteria-derived peptidoglycans constitute pathogen-associated molecular patterns triggering innate immunity in Arabidopsis. J Biol Chem (2007) 1.68

Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer? Microbiology (2005) 1.68

The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J (2006) 1.66

A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J Bacteriol (2002) 1.66

Arabidopsis lysin-motif proteins LYM1 LYM3 CERK1 mediate bacterial peptidoglycan sensing and immunity to bacterial infection. Proc Natl Acad Sci U S A (2011) 1.65

Dentin sialoprotein and dentin phosphoprotein have distinct roles in dentin mineralization. Matrix Biol (2009) 1.64

Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR. Mol Microbiol (2003) 1.61

Identification and characterization of a sphingolipid delta 4-desaturase family. J Biol Chem (2002) 1.60

Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity. J Bacteriol (2003) 1.59

Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson. Int J Med Microbiol (2004) 1.57

Biosynthesis of very-long-chain polyunsaturated fatty acids in transgenic oilseeds: constraints on their accumulation. Plant Cell (2004) 1.52

Inhibition of staphylococcal biofilm formation by nitrite. J Bacteriol (2007) 1.51

The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC Microbiol (2008) 1.51

Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol (2006) 1.50

Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J Infect Dis (2003) 1.44

Solitary spinal artery aneurysms as a rare source of spinal subarachnoid hemorrhage: potential etiology and treatment strategy. AJNR Am J Neuroradiol (2005) 1.43

The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect Immun (2006) 1.41

Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. Eur J Cell Biol (2009) 1.39

Novel fatty acid elongases and their use for the reconstitution of docosahexaenoic acid biosynthesis. J Lipid Res (2004) 1.39

Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc Natl Acad Sci U S A (2012) 1.39

Genome analysis of the meat starter culture bacterium Staphylococcus carnosus TM300. Appl Environ Microbiol (2008) 1.38

Cation-induced transcriptional regulation of the dlt operon of Staphylococcus aureus. J Bacteriol (2006) 1.35

Acyl carriers used as substrates by the desaturases and elongases involved in very long-chain polyunsaturated fatty acids biosynthesis reconstituted in yeast. J Biol Chem (2003) 1.35

Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids. Mol Microbiol (2011) 1.34

Microevolution of cytochrome bd oxidase in Staphylococci and its implication in resistance to respiratory toxins released by Pseudomonas. J Bacteriol (2006) 1.33

MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect Immun (2003) 1.32

Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J (2010) 1.31

Suicidal erythrocyte death in sepsis. J Mol Med (Berl) (2006) 1.30

Temporal expression of adhesion factors and activity of global regulators during establishment of Staphylococcus aureus nasal colonization. J Infect Dis (2010) 1.30

Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One (2010) 1.29

Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J Biol Chem (2010) 1.29

Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int J Med Microbiol (2008) 1.29

Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis (2008) 1.28

Macrolactin is the polyketide biosynthesis product of the pks2 cluster of Bacillus amyloliquefaciens FZB42. J Nat Prod (2007) 1.28

Bacterial resistance to antimicrobial host defenses--an emerging target for novel antiinfective strategies? Curr Drug Targets (2003) 1.27

N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation. Mol Cell Biol (2008) 1.27

Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol (2010) 1.26